4.8 Review

Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids

Journal

NATURE CELL BIOLOGY
Volume 23, Issue 8, Pages 822-833

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41556-021-00721-x

Keywords

-

Categories

Funding

  1. Intramural Research Program of the National Institutes of Health at the National Institute of Neurological Disorders and Stroke
  2. National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL119215]

Ask authors/readers for more resources

Complex organoids play important roles in studying SARS-CoV-2 infection, modeling COVID-19 pathology, and developing drugs, antibodies, and vaccines. There are significant opportunities and challenges in the application of organoids in COVID-19 research.
Studying SARS-CoV-2 in organoids. Chen et al. review the emerging roles of complex organoids in the study of SARS-CoV-2 infection, modelling of COVID-19 disease pathology and in drug, antibody and vaccine development. Clinical management of patients with severe complications of COVID-19 has been hindered by a lack of effective drugs and a failure to capture the extensive heterogeneity of the disease with conventional methods. Here we review the emerging roles of complex organoids in the study of SARS-CoV-2 infection, modelling of COVID-19 disease pathology and in drug, antibody and vaccine development. We discuss opportunities for COVID-19 research and remaining challenges in the application of organoids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available